The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ki67 as a prognostic factor in low grade serous ovarian cancer (LGSOC): A retrospective analysis of the Tumor Bank Ovarian Cancer (TOC).
 
Jalid Sehouli
Honoraria - AstraZeneca; PharmaMar; Roche Pharma AG; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novogene; Roche Pharma AG; Tesaro
Research Funding - Amgen (Inst); Bayer (Inst); Lilly (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - PharmaMar; Roche Pharma AG
 
Helmut Plett
No Relationships to Disclose
 
Rolf Richter
No Relationships to Disclose
 
Carsten Denkert
No Relationships to Disclose
 
Silvia Darb-Esfahani
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
 
Radoslav Chekerov
Honoraria - AstraZeneca; Medac; Roche Pharma AG
Travel, Accommodations, Expenses - Medac
 
Wolfgang D Schmitt
No Relationships to Disclose
 
J.P. Grabowski
Honoraria - AstraZeneca; Pfizer; Roche Pharma AG; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; Roche Pharma AG; Tesaro
Research Funding - AstraZeneca (Inst); Tesaro (Inst)
 
Eliane T Taube
No Relationships to Disclose
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Fujirebio Diagnostics; Myriad Genetics; Roche
Consulting or Advisory Role - Fujirebio Diagnostics; Glycotope GmbH
Research Funding - Takeda (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Myriad Genetics